Atlas Trials

Study of the Clearance of Minimal Residual Disease Measured at the End of First-line Treatment in Patients With Lymphoma

Clinical trial NCT06744075 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06744075
Sponsor
Centre Henri Becquerel
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
B-cell LymphomaHodgkin Lymphoma
Start date
2024-12-24
Primary completion
2027-12-20
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.